Reuters logo
BRIEF-Amphastar Pharma reports results for three months ended Sept
November 8, 2017 / 9:26 PM / 9 days ago

BRIEF-Amphastar Pharma reports results for three months ended Sept

Nov 8 (Reuters) - Amphastar Pharmaceuticals Inc

* Amphastar Pharmaceuticals reports financial results for the three months ended September 30, 2017

* Q3 GAAP earnings per share $0.00

* Q3 revenue $57.9 million versus i/b/e/s view $57.2 million

* Q3 adjusted non-GAAP earnings per share $0.07

* Q3 earnings per share view $0.02 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below